genetic-predisposition-for-celiac-disease Videos
4 videos found
At BioMarin we are tackling scientific problems that no one has worked on before and we are paving the way to develop new scientific discoveries. Learn more from our employees and why they enjoy working at BioMarin. BioMarin is a global biotechnology company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and ...
Mar. 10, 2021
ByBioMarin
20 years of rare opportunities. 20 years of personal impact. Despite being faced with potential demise during the company’s infancy, BioMarin persevered to become one of the world leaders in developing therapies for rare genetic diseases. Watch the 20 year journey of the people of BioMarin finding tomorrows by staying focused on the science to make a big difference for small patient ...
Mar. 10, 2021
ByBioMarin
The Alliance for Regenerative Medicine’s annual Cell & Gene State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This webinar includes ARM’s annual yearly update on the sector’s progress, followed by two panel sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year. ...
May. 30, 2022
The bottlenose dolphin is one of the most widely studied marine mammals. However, researchers are limited in the mapping of genetic diversity of wide populations. High quality genomes are essential to resolve challenges in breeding, comparative biology, medicine and conservation planning for bottlenose dolphins. See how an advanced assembly was completed and donated by a group of global ...
Aug. 13, 2021
ByNRGene